Patent Law Weblog
Category: Licensing
-
By Donald Zuhn — As we reported two weeks ago, Roche commenced a cash tender offer on June 27, 2007 to acquire all outstanding shares of Ventana Medical Systems, Inc. common stock. Ventana’s Board of Directors announced today (July 11, 2007) that it had reviewed Roche’s "unsolicited tender offer . . . and…
-
By Jason Derry — The National Institutes of Health (NIH) has announced the creation of a new resource to help promote NIH licensed technologies and technologies supported by funds from the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The resource is Web-based and referred to as the…
-
By Donald Zuhn — As we reported two weeks ago, Roche commenced a cash tender offer on June 27, 2007 to acquire all outstanding shares of Ventana Medical Systems, Inc. common stock. In the past week, however, it appears that Roche’s acquisition of Ventana may have hit a snag – or two. Last…
-
By Kevin E. Noonan — A measure of sanity returned last week, when the Brasilian Health Ministry and Abbott Laboratories announced an agreement on a pricing regime for Abbott’s anti-AIDS drug, Kaletra®. Under this agreement, Brasil will not "break" Abbott’s patent by permitting sale or importation of a generic version of the drug.…
-
By Christopher P. Singer — Alnylam Pharmaceuticals, Inc. and Roche announced on July 9, 2007 that they have entered into a non-exclusive license agreement in the area of RNA interference (RNAi) therapeutics. The agreement includes an upfront payment of $331 million from Roche to Alnylam, which includes cash payments, purchase of 1.975 million…
-
By Donald Zuhn — As we reported yesterday, Roche announced on Monday that it had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. Today, Roche announced that it has commenced a cash tender offer for all outstanding shares of Ventana common stock. The terms…
-
By Donald Zuhn — On Monday, Roche announced that it had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. According to a New York Times report, the Swiss-based biotech’s offer constitutes a 45% premium over Ventana’s Monday closing stock price of $51.74. According to…
-
By Christopher P. Singer — In a June 19, 2007 press release, NimbleGen Systems Inc. announced that it and Roche have entered into a definitive acquisition agreement. Under terms of the agreement Roche will pay $272.5 million to NimbleGen stockholders, and NimbleGen will become an integrated part of Roche Applied Science, a group…
-
By Donald Zuhn — On June 3, 2007, QIAGEN N.V. and Digene Corp. announced that the two companies would be combining to form a molecular diagnostics company worth approximately US$16.6 billion. The merger agreement calls for QIAGEN to acquire all of Digene’s stock for a combination of cash and QIAGEN common stock, with…
-
By Donald Zuhn — Last Thursday, Agilent Technologies Inc. announced that it had completed its $250 million acquisition of Stratagene Corp. Agilent had announced the agreement to acquire Stratagene, which develops, manufactures, and markets life science research and diagnostic products, two months earlier. Agilent bills itself as the world’s premier measurement company, specializing…
Patent Docs 